Clinical Trial Update: A Novel Single Arm Phase II Study for Relapsed Germ Cell Tumours With Poor Prognosis [Phase 2]

View source ↗

Summary

Single-arm Phase II trial evaluating a novel therapy for relapsed germ cell tumors with poor prognosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Germ Cell Tumor

Snippet

Sponsor: Barts & The London NHS Trust | Conditions: Germ Cell Tumour | Phase 2 | Status: COMPLETED